Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1999 2
2001 1
2002 1
2004 2
2005 1
2006 1
2009 2
2013 2
2014 1
2016 2
2017 1
2019 3
2020 3
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis.
Greuter T, Vavricka SR. Greuter T, et al. Expert Rev Gastroenterol Hepatol. 2019 Apr;13(4):307-317. doi: 10.1080/17474124.2019.1574569. Epub 2019 Feb 20. Expert Rev Gastroenterol Hepatol. 2019. PMID: 30791773 Review.
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder, primarily of, but not restricted to the gut. Extraintestinal manifestations (EIMs) are frequently observed and involve the joints, eyes, hepatobiliary tract, and skin. ...Several pathogenic mechanisms hav …
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder, primarily of, but not restricted to the gut. Extraintestinal man …
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.
Lynch KD, Chapman RW, Keshav S, Montano-Loza AJ, Mason AL, Kremer AE, Vetter M, de Krijger M, Ponsioen CY, Trivedi P, Hirschfield G, Schramm C, Liu CH, Bowlus CL, Estes DJ, Pratt D, Hedin C, Bergquist A, de Vries AC, van der Woude CJ, Yu L, Assis DN, Boyer J, Ytting H, Hallibasic E, Trauner M, Marschall HU, Daretti LM, Marzioni M, Yimam KK, Perin N, Floreani A, Beretta-Piccoli BT, Rogers JK; International Primary Sclerosing Cholangitis Study Group (IPSCSG), Levy C. Lynch KD, et al. Clin Gastroenterol Hepatol. 2020 Jan;18(1):179-187.e6. doi: 10.1016/j.cgh.2019.05.013. Epub 2019 May 14. Clin Gastroenterol Hepatol. 2020. PMID: 31100458 Free PMC article.
BACKGROUND & AIMS: Gut-homing lymphocytes that express the integrin alpha4beta7 and CCR9 might contribute to development of primary sclerosing cholangitis (PSC). ...Liver-related events occurred in 21 patients (20.6%), including bacterial …
BACKGROUND & AIMS: Gut-homing lymphocytes that express the integrin alpha4beta7 and CCR9 might contribute to development o …
Characterization of gut-homing molecules in non-endstage livers of patients with primary sclerosing cholangitis and inflammatory bowel disease.
de Krijger M, Visseren T, Wildenberg ME, Hooijer GKJ, Verstegen MMA, van der Laan LJW, de Jonge WJ, Verheij J, Ponsioen CY. de Krijger M, et al. J Transl Autoimmun. 2020 Apr 9;3:100054. doi: 10.1016/j.jtauto.2020.100054. eCollection 2020. J Transl Autoimmun. 2020. PMID: 32743534 Free PMC article.
INTRODUCTION: The co-occurrence of inflammatory bowel disease (IBD) in up to 80% of patients with primary sclerosing cholangitis (PSC) suggests a relation between the gut and the liver in patients with both PSC and IBD. ...This intense staining pattern …
INTRODUCTION: The co-occurrence of inflammatory bowel disease (IBD) in up to 80% of patients with primary sclerosing cholan
Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis.
Borchers AT, Shimoda S, Bowlus C, Keen CL, Gershwin ME. Borchers AT, et al. Semin Immunopathol. 2009 Sep;31(3):309-22. doi: 10.1007/s00281-009-0167-2. Epub 2009 Jun 17. Semin Immunopathol. 2009. PMID: 19533132 Free PMC article. Review.
The mechanisms operating in lymphocyte recruitment and homing to liver are reviewed. A literature review was performed on primary biliary cirrhosis (PBC), progressive sclerosing cholangitis (PSC), and homing mechanisms; a total of …
The mechanisms operating in lymphocyte recruitment and homing to liver are reviewed. A literature review was performed …
Return to sender: Lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitis.
de Krijger M, Wildenberg ME, de Jonge WJ, Ponsioen CY. de Krijger M, et al. J Hepatol. 2019 Sep;71(3):603-615. doi: 10.1016/j.jhep.2019.05.006. Epub 2019 May 18. J Hepatol. 2019. PMID: 31108158 Review.
Primary sclerosing cholangitis (PSC) is an inflammatory disease of the biliary tree, characterised by stricturing bile duct disease and progression to liver fibrosis. ...The concurrence with inflammatory bowel disease (IBD) in about 70% of cases has led to th
Primary sclerosing cholangitis (PSC) is an inflammatory disease of the biliary tree, characterised by stricturing bile
Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis: Data From the Pediatric Primary Sclerosing Cholangitis Consortium.
Laborda TJ, Ricciuto A, Aumar M, Carman N, DiGuglielmo M, Draijer LG, Furuya KN, Gupta N, Koot BGP, Loomes KM, Lytvyak E, Martinez M, Miloh T, Montano-Loza AJ, Perito ER, Sathya P, Shah U, Shteyer E, Singh R, Taylor A, Valentino PL, Vitola B, Zerofsky M, Zizzo A, Deneau MR. Laborda TJ, et al. J Pediatr Gastroenterol Nutr. 2020 Oct;71(4):459-464. doi: 10.1097/MPG.0000000000002855. J Pediatr Gastroenterol Nutr. 2020. PMID: 32740528
OBJECTIVES: Most patients with primary sclerosing cholangitis (PSC) also have inflammatory bowel disease (IBD). The liver and colon express MAdCAM-1, a target of lymphocyte homing integrins. Vedolizumab (VDZ) is an alpha4beta7 integrin antibody …
OBJECTIVES: Most patients with primary sclerosing cholangitis (PSC) also have inflammatory bowel disease (IBD). The liv …
New Therapeutic Strategies for Primary Sclerosing Cholangitis.
Williamson KD, Chapman RW. Williamson KD, et al. Semin Liver Dis. 2016 Feb;36(1):5-14. doi: 10.1055/s-0035-1571274. Epub 2016 Feb 12. Semin Liver Dis. 2016. PMID: 26870928 Review.
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease, which in the majority of patients progresses to liver transplantation or death. ...Recent studies have suggested that the microbiome may play a role in PSC, raising the possibility o
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease, which in the majority of patients progress
Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis.
Eksteen B, Grant AJ, Miles A, Curbishley SM, Lalor PF, Hübscher SG, Briskin M, Salmon M, Adams DH. Eksteen B, et al. J Exp Med. 2004 Dec 6;200(11):1511-7. doi: 10.1084/jem.20041035. Epub 2004 Nov 22. J Exp Med. 2004. PMID: 15557349 Free PMC article.
Primary sclerosing cholangitis (PSC), a chronic inflammatory liver disease characterized by progressive bile duct destruction, develops as an extra-intestinal complication of inflammatory bowel disease (IBD) (Chapman, R.W. 1991. ...In support of this, we show
Primary sclerosing cholangitis (PSC), a chronic inflammatory liver disease characterized by progressive bile duct destr
Primary sclerosing cholangitis: a review and update on therapeutic developments.
Tabibian JH, Lindor KD. Tabibian JH, et al. Expert Rev Gastroenterol Hepatol. 2013 Feb;7(2):103-14. doi: 10.1586/egh.12.80. Expert Rev Gastroenterol Hepatol. 2013. PMID: 23363260 Review.
Primary sclerosing cholangitis (PSC) is a chronic, cholestatic, idiopathic liver disease characterized by fibro-obliterative inflammation of the hepatic bile ducts. ...
Primary sclerosing cholangitis (PSC) is a chronic, cholestatic, idiopathic liver disease characterized by fibro-obliter
Immunopathogenesis of primary sclerosing cholangitis.
Worthington J, Cullen S, Chapman R. Worthington J, et al. Clin Rev Allergy Immunol. 2005 Apr;28(2):93-103. doi: 10.1385/CRIAI:28:2:093. Clin Rev Allergy Immunol. 2005. PMID: 15879616 Review.
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown etiology;however, lymphocytic portal tract infiltration is suggestive of an immune-mediated basis for PSC. ...The immunogenetics of PSC have been the subject of active rese
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown etiology;however, lymphocytic po
23 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page